Current Topics in Behavioral Neurosciences
March 22, 2022
Marina Kojić, Johan Saelens, Bashkim Kadriu et al.
11 citations
The approval of ketamine for treatment-resistant depression has created a model for a novel class of rapid-acting glutamatergic antidepressants. Recent research into other novel rapid-acting antidepressants – most notably serotonergic psychedelics (SPs) – has also proven promising. Presently, the mechanisms of action of these substances are under investigation to improve these novel treatments,...
Depression and Anxiety
March 21, 2022
Holger C Bringmann, Andreas Michalsen, Michael Jeitler et al.
Depression is a global key challenge in mental health care. The implementation of effective, low‐risk and cost‐effective interventions to reduce its disease burden is a necessity. The aim of this study was to investigate the efficacy of the new Meditation‐Based Lifestyle Modification (MBLM) program, a “second‐generation” mindfulness‐based intervention, in depressive outpatients.
Journal of the Neurological Sciences
March 15, 2022
Darin F Quach, Victoria C De Leon, Charles R Conway
Stemming from the results of the historic STAR-D trial, it is evident that a significant subset of individuals (20-25%) with major depressive disorder (MDD) do not respond to conventional antidepressant medications. As a result, an emphasis has been placed on the development of novel therapeutics for MDD over the last two decades. Recently, substantial research efforts have been focused on the...
Expert Opinion on Drug Safety
March 9, 2022
Anees Bahji, Carlos A. Zarate, Gustavo Vazquez
71 citations
ABSTRACT Background Racemic ketamine and esketamine have demonstrated rapid antidepressant effects. We aimed to review the efficacy and safety of racemic and esketamine for depression. Research design and methods We conducted a PRISMA-guided review for relevant randomized controlled trials of racemic or esketamine for unipolar or bipolar major depression from database inception through 2021. We...
International Journal of Science and Research (IJSR)
March 5, 2022
C Srilatha, G Deepika
Introduction: Nursing professionals, working in COVID pandemic situation are exposed to various infectious diseases, including those transmitted through the blood or other body fluids and/or airborne infectious agents, the Nursing professionals who are in direct contact with the patients are exposed to highest levels of risk. Nurses are particularly vulnerable to many job-related hazards, and...
Can J Kidney Health Dis
March 4, 2022
Long-term Effects of a Brief Mindfulness Intervention Versus a Health Enhancement Program for Treating Depression and Anxiety in Patients Undergoing Hemodialysis: A Randomized Controlled Trial.
Indian Journal of Psychiatry
March 1, 2022
Many experts believes this undoubtedly that Panic is dangerous than pandemic. Fear, stress, anxiety, depression and obsession out of continuous panic state of mind would be more dangerous than the infection caused by covid19 corona virus during pandemic because if one member of a family is infected by infection than all other members of same family were found to be suffering from the stress and...
Behavioral Science
March 1, 2022
Andrea Poli, A. G. Maremmani, Angelo Gemignani et al.
Mindfulness is a mental state that can be achieved through meditation. So far, studies have shown that practicing mindfulness on a consistent and regular basis can improve attentional functions and emotional well-being. Mindfulness has recently begun to be used in the field of child development. The goal of this study is to assess if a mindfulness program may help primary school students in...
Indian Journal of Psychiatry
March 1, 2022
Deoshree Akhouri, M. Madiha, Owais Ashraf et al.
Background: Irritable Bowel Syndrome (IBS) is a disorder of gastrointestinal system, characterized by abdominal pain, diarrhoea, constipation, or both. IBS-M (diarrhoea and constipation) has reported to cause significant distress to the person and often goes misdiagnosed; leading to different psychological problems such as stress, anxiety, depression, etc. These psychological problems maintain...
Psychology and Psychotherapy Theory Research and Practice
March 2022
Kate Williams, Samantha Hartley, Ian M. Anderson et al.
Mindfulness-based cognitive therapy (MBCT) is an 8-week relapse-prevention intervention designed for people who have experienced multiple episodes of depression and remain vulnerable to relapse. Previous qualitative explorations of the effects of MBCT for people in remission from depression have suggested a number of themes regarding changes arising from participating in MBCT ranging from...